Description

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule NNMT inhibitor designed for research into metabolic regulation and cellular energy balance. By blocking nicotinamide N-methyltransferase (NNMT), it elevates NAD+ levels, activates SIRT1 pathways, and promotes fat oxidation, mitochondrial biogenesis, and insulin sensitivity in preclinical models. Often studied at 5mg doses for lab exploration of obesity, weight management, and anti-aging mechanisms, it offers oral bioavailability advantages over traditional peptides.

Product Specifications